---
title: "EW Analyst Ratings and Price Target - Edwards Lifesciences Stock Forecast | Tradytics"
description: "Edwards Lifesciences (EW) analyst ratings, the average price target and its range, and every firm's latest call."
url: "https://tradytics.com/research/EW/analysts"
image: "https://tradytics.com/api/v2/og/research.png?id=EW&v=stock-11994872"
---

# EW analyst estimates

Edwards Lifesciences (EW) analyst ratings, the average price target and its range, and every firm's latest call.

- 18 firms rate EW: 15 buy, 3 hold, 0 sell.
- The average price target is $109.20 from None analysts, from $100.00 to $120.00.

## EW analyst ratings and price targets

| Date | Firm | Call | Target |
| --- | --- | --- | --- |
| Nov 20, 2026 | RBC Capital | RBC Capital on Edwards Lifesciences (EW): 'Top-Tier Large Cap MedTech Growth Expected to Continue in 2027' | $115.00 |
| Nov 5, 2026 | Mizuho Securities | Edwards Lifesciences (EW) PT Raised to $120 at Mizuho | $120.00 |
| Nov 5, 2026 | Wells Fargo | Edwards Lifesciences (EW) PT Raised to $113 at Wells Fargo | $113.00 |
| Nov 5, 2026 | Truist Financial | Edwards Lifesciences (EW) PT Raised to $118 at Truist Securities | $118.00 |
| Nov 4, 2026 | Truist Financial | Truist Securities Upgrades Edwards Lifesciences (EW) to Buy | $113.00 |
| Oct 27, 2026 | Deutsche Bank | TD Cowen Reiterates Buy Rating on Edwards Lifesciences (EW) | $104.00 |
| Jul 28, 2026 | UBS | Edwards Lifesciences upgraded to Buy from Neutral at UBS | $110.00 |
| Jul 24, 2026 | Leerink Partners | Edwards Lifesciences upgraded to Outperform from Market Perform at Leerink | $101.00 |
| Jul 24, 2026 | Piper Sandler | Edwards Lifesciences price target raised to $101 from $100 at Piper Sandler | $101.00 |
| Jul 16, 2026 | Truist Financial | Edwards Lifesciences price target raised to $95 from $90 at Truist | $95.00 |
| Jul 13, 2026 | RBC Capital | Edwards Lifesciences price target raised to $110 from $100 at RBC Capital | $110.00 |
| Jul 6, 2026 | Evercore ISI | Edwards Lifesciences price target raised to $100 from $93 at Evercore ISI | $100.00 |
| Jun 30, 2026 | BTIG | Edwards Lifesciences price target raised to $110 from $100 at BTIG | $110.00 |
| Apr 27, 2026 | Barclays | Edwards Lifesciences price target raised to $110 from $104 at Barclays | $110.00 |
| Apr 24, 2026 | Truist Financial | Edwards Lifesciences price target raised to $90 from $89 at Truist | $90.00 |

- [EW stock analysis](https://tradytics.com/research/EW)
- [EW options overview](https://tradytics.com/research/EW/options)
- [EW earnings](https://tradytics.com/research/EW/earnings)
- [EW financials](https://tradytics.com/research/EW/financials)
- [EW peer analysis](https://tradytics.com/research/EW/peers)
- [EW insider trading](https://tradytics.com/research/EW/insiders)
- [EW congressional trades](https://tradytics.com/research/EW/politicians)
- [EW institutional holdings](https://tradytics.com/research/EW/funds)
- [EW live chart](https://tradytics.com/charts?s=EW)
- [Read the data without JavaScript](https://tradytics.com/research/EW/analysts?snapshot=1)
